| Sign In to gain access to subscriptions and/or personal tools. |
Persistent Growth Failure in Prader-Willi Syndrome Associated With Short-Chain Acyl-CoA Dehydrogenase Gene VariantDepartment of Neurosciences, Medical University of South Carolina, Charleston
Hospital Escuela Materno-Infantil, Tegucigalpa, Honduras, Central America
Greenwood Genetic Center, Greenwood, South Carolina
Greenwood Genetic Center, Greenwood, South Carolina
Department of Neurosciences, Medical University of South Carolina, Charleston, kholden{at}ggc.org, Greenwood Genetic Center, Greenwood, South Carolina The authors report the rare association of Prader-Willi syndrome and short-chain acyl-CoA dehydrogenase gene variant. Prader-Willi syndrome, associated with paternal chromosome 15q11-q13 silencing, is characterized by neonatal/infantile hypotonia, growth failure, and neurodevelopmental delays in the first 1 to 2 years of life, typically followed by hyperphagia and obesity. Short-chain acyl-CoA dehydrogenase gene variant, with 625 G-to-A and 511 C-to-T changes, impairs C4-C6 fatty acid metabolism and variably causes neonatal/infantile hypotonia with developmental delays. The authors' patient continues to exhibit the classic severe growth failure of early infancy Prader-Willi syndrome at 40 months. Extensive laboratory investigations indicate that the short-chain acyl-CoA dehydrogenase gene variant is likely preventing or delaying the normal expression of the Prader-Willi syndrome phenotype.
Key Words: neurodevelopment metabolism short-chain acyl-CoA dehydrogenase failure to thrive Prader-Willi
Journal of Child Neurology, Vol. 23, No. 1,
112-117 (2008) |
|
||

